| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Talphera, Inc. (TLPH) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 2 sells. TLPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 577.4K | $522.0K | - | |
| Other | 205.0K | $185.3K | - | |
| CFO | 88.3K | $79.8K | - | |
| Other | 73.9K | $66.8K | - | |
| Dir | 38.4K | $34.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2018 | Edwards Mark G | Director | Buy | 5,000 | $3.35 | $16,735.00 | +1.7% | |
| May 25, 2018 | Asadorian Raffi | Chief Financial Officer | Buy | 5,000 | $3.18 | $15,922.50 | +22.7% | |
| Nov 14, 2017 | Edwards Mark G | Director | Buy | 30,000 | $1.90 | $56,970.00 | +25.0% | |
| Nov 13, 2017 | Asadorian Raffi | Chief Financial Officer | Buy | 5,000 | $1.94 | $9,710.50 | +71.4% | |
| Oct 2, 2017 | Hamel Lawrence G | Chief Development Officer | Sell | 10,161 | $5.29 | $53,751.69 | -19.5% | |
| Sep 25, 2017 | Hamel Lawrence G | Chief Development Officer | Sell | 13,827 | $0.00 | - | -16.8% | |
| Sep 11, 2017 | Asadorian Raffi | Chief Financial Officer | Buy | 7,000 | $3.24 | $22,705.20 | New | |
| Aug 24, 2017 | Angotti Vincent J.55 | Chief Executive Officer | Buy | 15,000 | $3.00 | $45,000.00 | New | |
| Aug 24, 2017 | Edwards Mark G | Director | Buy | 5,000 | $3.02 | $15,100.00 | +2.2% | |
| Aug 22, 2017 | Palmer Pamela P | Chief Medical Officer | Buy | 10,000 | $2.95 | $29,487.00 | +2.5% |